NOVEL RP-HPLC METHOD FOR THE ... - Ijsidonline.info

Thamma Narendra Kumar et al., IJSID, 2011, 1 (3), 395-4213. Nair S, Diehl AM, Wiseman M, Farr GH Jr, Perrillo RP. Metformin in the treatment of non-alcoholicsteatohepatitis: a pilot open label trial. Aliment Pharmacol Ther. 2004;20(1):23–28.4. Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F.Drugs improving insulin resistance for non-alcoholicfatty liver disease and/or non-alcoholic steatohepatitis. Cochrane Database Syst Rev. 2007;24(1):CD005166.5. Socha P, Horvath A, Vajro P, Dziechciarz P, Dhawan A, Szajewska H. Pharmacological interventions fornonalcoholic fatty liver disease in adults and in children: a systematic review.J Pediatr Gastroenterol Nutr.2009;48(5):587–96.6. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet. 1998;352(9131):854–65.7. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2diabetes.N Engl J Med. 2008;359(15):1577–89.8. Selvin E, Bolen S, Yeh HC, et al. Cardiovascular outcomes in trials of oral diabetes medications: a systematicreview. Arch Intern Med. 2008;168(19):2070–80.9. Saeedi R, Parsons HL, Wambolt RB, et al. Metabolic actions of metformin in the heart can occur by AMPKindependentmechanisms. Am J Physiol Heart Circ Physiol. 2008;294(6):H2497–506.10. Werner E, Bell J. The preparation of methylguanidine, and of ββ-dimethylguanidine by the interaction ofdicyanodiamide, and methylammonium and dimethylammonium chlorides respectively. J Chem Soc,Transactions. 1921;121:1790–5.11. Shapiro SL, Parrino VA, Freedman L. Hypoglycemic Agents. I Chemical Properties of β-Phenethylbiguanide. ANew Hypoglycemic Agent. J Am Chem Soc. 1959;81(9):2220–5.12. Bharatam PV, Patel DS, Iqbal P,. Pharmacophoric Features of Biguanide Derivatives: An Electronic andStructural Analysis. J Med Chem. 2005;48(24):7615–7622.13. Patel DS, Bharatam PV. Novel N(L)2 species with two lone pairs on nitrogen: systems isoelectronic tocarbodicarbenes.Chem Commun. 2009;(9):1064–6.14. Heller JB. Metformin overdose in dogs and cats.Veterinary Medicine. 2007;(April):231–233.15. Garry G. Graham, Jeroen Punt, Manit Arora, Richard O. Day, Matthew P. Doogue, Janna K. Duong, Timothy J.Furlong, Jerry R. Greenfield, Louise C. Greenup, Carl M. Kirkpatrick, John E. Ray, Peter Timmins and Kenneth M.Williams. Clinical Pharmacokinetics of Metformin. Clin Pharmacokinet 2011; 50 (2): 81-9816. Robert F, Fendri S, Hary L, Lacroix C, Andréjak M, Lalau JD.Kinetics of plasma and erythrocyte metformin afteracute administration in healthy subjects. Diabetes Metab. 2003;29(3):279–83.17. See Chemical Abstracts, v.23, 42772 (1929) Werner E, Bell J. Uber Biguanide. II. Die BlutzuckersenkendeWirkung der Biguanides. Berichte der Deutschen Chemischen Gesellschaft B: Abhandlungen. 1929;62:1398–1405.International Journal of Science Innovations and Discoveries Vol 1, Issue 3, November-December 2011420